PharmaBoardroom

Accelerated Regulatory Assessment of Innovative Medicines in…

Writing in the March edition of DIA’s Global Forum magazine, EMD Serono's Ana Padua outlines the findings of a recent study into accelerated…

The COVID-19 Vaccine Rush: Nationalism, Access & IP Issues

The global rush to secure access to COVID-19 vaccines has led to accusations that richer countries are hoarding supply at the expense of poorer…

Nicolas Fischer – CEO, Light Chain Bioscience

Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and development of bispecific antibodies using…

Alessandro Riva – CEO, Ichnos Sciences

Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in oncology R&D at Novartis and…

Nawal Roy – Founder & CEO, Holmusk

Nawal Roy of global digital health platform Holmusk which aims to establish data as a core utility to the treatment of behavioural health disorders…

Public Insurance Coverage for Rare Disease Patients in China:…

Kevin Rufang Huang, president and founder of the Chinese Organization for Rare Disorders (CORD), outlines the findings of the first ever analysis into…

Italy: Stevanato’s $5 bn valuation; Zolgensma Approval; Sputnik…

The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine contracts, glass vial manufacturer…

Japan PMDA New Drug Approvals 2020

Following on from our recent compilations of 2020 new drug approvals in the USA, China, and Switzerland, see below for the Japanese PMDA's new drug…

Dan Leonard – President & CEO, Association for…

Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his key agenda priorities as head of the…